Archives

  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-08
  • 2025-07
  • 2025-06
  • DNase I (RNase-free): Gold-Standard Endonuclease for DNA ...

    2026-01-28

    DNase I (RNase-free): Gold-Standard Endonuclease for DNA Removal in RNA Extraction

    Executive Summary: DNase I (RNase-free) (SKU K1088, APExBIO) is a highly purified endonuclease that digests both single- and double-stranded DNA, yielding 5'-phosphorylated and 3'-hydroxylated oligonucleotides [APExBIO product page]. Its activity is strictly dependent on divalent cations, primarily Ca2+ for stability and Mg2+ or Mn2+ for catalysis, enabling random cleavage of DNA under physiological conditions (Schuth et al. 2022, DOI). The enzyme is RNase-free, making it indispensable for removing DNA during RNA purification, in vitro transcription, and RT-PCR sample prep. Benchmark studies confirm its effectiveness in complex biological samples, including tumor organoid cultures. Key workflow parameters, supported by peer-reviewed evidence, are summarized herein.

    Biological Rationale

    Removal of contaminating DNA is a critical step in RNA analysis workflows. DNA can introduce false positives or elevate background in RT-PCR and RNA-seq. In advanced models—such as 3D organoid-fibroblast co-cultures used to study tumor microenvironment and chemoresistance—precise DNA removal is essential for accurate transcriptomic profiling (Schuth et al. 2022, DOI). DNase I (RNase-free) is specifically engineered for this role, ensuring that DNA is fully digested without compromising RNA integrity. Its utility extends to in vitro transcription, chromatin research, and nucleic acid metabolism studies. The enzyme’s RNase-free status is vital for downstream applications in transcriptomics and molecular diagnostics.

    Mechanism of Action of DNase I (RNase-free)

    DNase I (RNase-free) is an endonuclease that cleaves phosphodiester bonds within DNA. The enzyme requires Ca2+ ions for structural stability and is catalytically activated by either Mg2+ or Mn2+ ions. In the presence of Mg2+ (typically 5–10 mM), DNase I cleaves double-stranded DNA randomly, while Mn2+ (1 mM) enables synchronized cleavage of both DNA strands at nearly identical positions, producing shorter oligonucleotides (APExBIO, product documentation). The cleavage generates 5′-phosphorylated and 3′-hydroxylated ends, facilitating further enzymatic or chemical processing. The enzyme digests a broad range of DNA substrates—single-stranded DNA, double-stranded DNA, chromatin, and RNA:DNA hybrids—without affecting RNA.

    Evidence & Benchmarks

    • DNase I (RNase-free) efficiently eliminates genomic DNA contamination during RNA extraction, yielding high-purity RNA suitable for RT-PCR and transcriptomics (Schuth et al. 2022).
    • The enzyme remains active and stable when stored at -20°C for up to 24 months, with no measurable loss of activity (APExBIO datasheet: product page).
    • In 3D PDAC organoid-fibroblast co-culture models, DNase I treatment enables accurate single-cell RNA-seq by removing extracellular DNA and minimizing background (Schuth et al. 2022, DOI).
    • RNase-free formulation is confirmed by rigorous testing; no detectable RNase activity is observed in standard assays at recommended concentrations (APExBIO).
    • DNase I (RNase-free) outperforms legacy DNase enzymes in specificity and reliability as detailed in this comparative article, which this review extends by providing new evidence from recent tumor microenvironment models.

    Applications, Limits & Misconceptions

    DNase I (RNase-free) is widely used for:

    • DNA removal for RNA extraction and RT-PCR
    • Preparation of cell-free RNA for in vitro transcription
    • Digestion of chromatin to study DNA–protein interactions
    • Clearing DNA in nucleic acid metabolism pathway research
    • Facilitating reproducibility in 3D organoid and co-culture systems, as highlighted in this reference. This article updates those insights by detailing recent single-cell sequencing applications.

    Limits and boundaries include:

    • DNase I (RNase-free) does not degrade RNA; it is not suitable for applications requiring RNA removal.
    • Enzyme activity is abolished by chelating agents (e.g., EDTA) due to divalent cation dependency.
    • High concentrations of detergents or denaturants can reduce enzyme efficiency.
    • Optimal activity is observed at pH 7.5–8.0 and 37°C in 10X DNase I buffer supplied with the kit.

    Common Pitfalls or Misconceptions

    • Myth: DNase I (RNase-free) can remove RNA contamination.
      Fact: It is DNA-specific and does not degrade RNA.
    • Myth: Enzyme works in any buffer.
      Fact: Chelators such as EDTA or EGTA inactivate DNase I by sequestering essential Ca2+/Mg2+ ions.
    • Myth: All DNase I preparations are RNase-free.
      Fact: Only RNase-free certified products, such as APExBIO’s DNase I (RNase-free), are validated for RNA workflows.
    • Myth: Heat inactivation fully destroys enzyme activity.
      Fact: DNase I may require chemical inactivation or removal by phenol-chloroform after use.

    Workflow Integration & Parameters

    For optimal DNA removal, add DNase I (RNase-free) during or after RNA extraction, using the supplied 10X DNase I buffer (100 mM Tris-HCl, pH 7.5, 25 mM MgCl2, 5 mM CaCl2). Incubate at 37°C for 10–30 minutes, adjusting enzyme concentration based on substrate DNA load (APExBIO: protocol). After digestion, inactivate or remove the enzyme by phenol-chloroform extraction or DNase inactivation reagents. Store the K1088 kit at -20°C to preserve activity. See scenario-driven integration strategies and troubleshooting guidance in this best practices article, which this review expands by providing protocol parameterization for single-cell and organoid workflows.

    Conclusion & Outlook

    DNase I (RNase-free) (SKU K1088) from APExBIO is the reference enzyme for DNA removal in RNA-centric molecular biology. Its stringent RNase-free status, divalent cation-tuned specificity, and validated performance in complex models (e.g., PDAC organoid-fibroblast co-cultures) position it as an essential tool from bench to clinic (Schuth et al. 2022, DOI). Future directions include integration into automated workflows and expanded benchmarking across novel single-cell and spatial transcriptomics platforms. For product details and technical documentation, visit the DNase I (RNase-free) product page.